{"DataElement":{"publicId":"7008673","version":"1","preferredName":"Neoplasm Histologic Grade","preferredDefinition":"The degree of abnormality of cancer cells.","longName":"MIHSTGRD","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7008634","version":"1","preferredName":"Microscopic Findings Domain Neoplasm Histologic Grade","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"6407670v1.0:6421691v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407670","version":"1","preferredName":"Microscopic Findings Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","longName":"C95095","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Findings Domain","conceptCode":"C95095","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3D377-A300-2627-E053-F662850A04B0","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6421691","version":"1","preferredName":"Neoplasm Histologic Grade","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"C3262:C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480AD77-6D18-2B5F-E053-F662850AE28E","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"953057C5-AC77-3630-E053-F662850ABFF7","latestVersionIndicator":"Yes","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"HARTLEYG","dateModified":"2020-06-17","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2785835","version":"1.2","preferredName":"Histologic Grade","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A position on a scale of intensity or amount or quality.","longName":"HIST_GD","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intermediate Grade","valueDescription":"Intermediate Grade","ValueMeaning":{"publicId":"3335158","version":"1","preferredName":"Intermediate Grade","longName":"3335158","preferredDefinition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4E4B-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8C149354-7625-64FC-E053-F662850AE4E2","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","deletedIndicator":"No"},{"value":"G2","valueDescription":"Moderately Differentiated","ValueMeaning":{"publicId":"2559269","version":"1","preferredName":"Moderately Differentiated","longName":"2559269v1.00","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B492-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D165-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Low Grade","valueDescription":"Low Grade","ValueMeaning":{"publicId":"3288210","version":"1","preferredName":"Low Grade","longName":"3288210","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B13C-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D16F-725E-E053-F662850AB0CE","beginDate":"2013-02-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"High Grade","valueDescription":"High Grade","ValueMeaning":{"publicId":"3288211","version":"1","preferredName":"High Grade","longName":"3288211","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B15F-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D179-725E-E053-F662850AB0CE","beginDate":"2013-02-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G1","valueDescription":"Well Differentiated","ValueMeaning":{"publicId":"3685458","version":"1","preferredName":"Well Differentiated","longName":"3685458v1.00","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A18-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D183-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G4","valueDescription":"Undifferentiated Histology","ValueMeaning":{"publicId":"2560389","version":"1","preferredName":"Undifferentiated Histology","longName":"2560389v1.00","preferredDefinition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B8F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D197-725E-E053-F662850AB0CE","beginDate":"2008-09-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G3","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"3685459","version":"1","preferredName":"Poorly Differentiated","longName":"3685459","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A3B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D18D-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"GB","valueDescription":"Borderline Histologic Grade","ValueMeaning":{"publicId":"3685460","version":"1","preferredName":"Borderline Histologic Grade","longName":"3685460","preferredDefinition":"Straddling the dividing line between two categories.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline","conceptCode":"C14157","definition":"Straddling the dividing line between two categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D58D9008-3A6B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2013-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1A1-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"GX","valueDescription":"Grade Cannot be Assessed","ValueMeaning":{"publicId":"3685461","version":"1","preferredName":"Grade Cannot be Assessed","longName":"3685461","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D58DFA07-74C5-5942-E040-BB89AD4372FC","latestVersionIndicator":"Yes","beginDate":"2013-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"COOPERM","dateModified":"2013-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1AB-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1B5-725E-E053-F662850AB0CE","beginDate":"2019-04-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"097FBB3F-C7B2-6402-E063-731AD00A7379","beginDate":"2023-11-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-06","modifiedBy":"CLOHNES","dateModified":"2023-11-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2786701","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Of or relating to histology.:A position on a scale of intensity or amount or quality.","longName":"C25526:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57451CD6-05F6-28B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-19","modifiedBy":"ONEDATA","dateModified":"2008-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3FEE8-D150-725E-E053-F662850AB0CE","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"CLOHNES","dateModified":"2023-11-06","changeDescription":"5/28/2019 added new version due to max length changes, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318328","version":"1","longName":"Diagnosis - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318679","version":"1","longName":"Diagnosis CRF - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 2785839 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"Tumor grade","type":"Preferred Question Text","description":"Tumor grade","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"95312EA8-41E6-4E65-E053-F662850A37D8","latestVersionIndicator":"Yes","beginDate":"2019-10-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-18","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}